Kuter, D. J., Miura, K., Patriarca, A., Pulanić, D., Radinoff, A., Sapunarova, K., Syrigou, A., Yang, R., Nguyen, V. A., Skelton, E., Wang, S., Yee, D. L., Patwari, P. (2026). A Phase 2 Randomized Trial of Mezagitamab in Primary Immune Thrombocytopenia. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2513120